Commit to Quit

Highlights
Program Title Commit to Quit
Purpose Designed to test the efficacy of vigorous-intensity physical activity as an aid for smoking cessation for women. (1999)
Program Focus Behavior Modification
Population Focus Current Smokers
Topic Tobacco Control, Physical Activity
Age Adults (40-65 years), Young Adults (19-39 years)
Gender Female
Race/Ethnicity This information has not been reported.
Setting Community
Origination United States
Funded by NCI (Grant number(s): CA01757, CA59660)
RTIPs Scores
This program has been rated by external peer reviewers. Learn more about RTIPs program review ratings.
Research Integrity
4.5
Intervention Impact for Tobacco
3.0
Intervention Impact for Physical Activity
3.5
Dissemination Capability
4.0
(1.0 = low    5.0 = high)
RE-AIM Scores
Beginning in 2012, new programs are scored on RE-AIM criteria. This program was posted prior to the inclusion of RE-AIM scores and does not have these scores included. Click on the information icon next to "RE-AIM Scores" above to learn more about RE-AIM.

The Need

Tobacco dependence continues to be the leading, preventable cause of cancer, coronary heart disease, emphysema, respiratory infections, and bronchitis. Although smoking prevalence rates are declining for both women and men, the decline is slower for women. One reason is that while men and women have similar quit rates, men are able to refrain from tobacco use for longer periods. This has prompted requests for smoking cessation programs designed specifically for women. Variables such as concerns about weight gain, the belief that smoking reduces stress, and the need for social support have been identified as particularly relevant to smoking cessation programs for women. Participation in regular, vigorous physical exercise may be an alternative to smoking that may aid cessation efforts among female smokers. Exercise may address psychosocial and physiological needs that cannot be achieved with nicotine replacement therapy alone. 

Back to Top

The Program

Description

Geared toward adult female smokers, Commit to Quit is a 12-session, group-based, cognitive-behavioral smoking cessation program and exercise regimen tailored specifically to each participant. The cognitive-behavioral program includes traditional topics: self-monitoring, stimulus control, coping with cravings and high-risk situations, stress management, and relaxation techniques. Also included are topics of particular importance to women: healthy eating, weight management, mood management, and balancing work and family. The exercise component involves attending three exercise sessions per week. Exercise sessions consist of a 5-minute warm-up, 30-40 minutes of aerobics, and a 5-minute cool-down with stretching. Each person is given an exercise prescription calculated from the peak heart rate achieved on a baseline exercise test. 

Implementation Guide

The Implementation Guide is a resource for implementing this program. It provides important information about the staffing and functions necessary for administering this program in the user's setting. Additionally, the steps needed to carry out the research-tested program, relevant program materials, and information for evaluating the program are included. The Implementation Guide can be viewed and downloaded in the Products page.

Back to Top

Community Preventive Services Task Force Finding

Guide to Community Preventive Services This program is an example of individually-adapted health behavior change programs (Physical Activity), which is recommended by the Community Preventive Services Task Force, as found in the Guide to Community Preventive Services.
Back to Top

Time Required

The program requires 12 weeks to implement. Participants attend the group-based, cognitive-behavioral smoking cessation program once per week and three 40-50 minute exercise sessions per week.

Back to Top

Intended Audience

The intended audience for the Commit to Quit program is adult female smokers.

Back to Top

Suitable Settings

The program is suitable for implementation wherever group-based smoking cessation treatment is offered and at exercise facilities.

Back to Top

Required Resources

The materials required for this program are the Commit to Quit Patient Manual, the Commit to Quit Leader's Manual, and the Commit to Quit Exercise Protocol. It is recommended that leaders of the cognitive-behavioral program have a background in health promotion and wellness and that exercise staff have an exercise science degree.

Back to Top

About the Study

Participants took part in a randomized controlled clinical trial to assess the efficacy of cognitive behavioral therapy and vigorous aerobic exercise in promoting smoking cessation, improving exercise performance, and reducing weight gain. All treatment and control subjects participated in a 12-week, group-based, cognitive-behavioral smoking cessation program. Participants in the Commit to Quit group were also required to attend three exercise sessions per week, including one supervised session per week on their smoking cessation treatment night. Participants in the contact control condition also participated in a 12-week wellness program, attending three 45-60 minute supervised sessions per week, consisting of lectures, handouts, films, and discussions addressing women's health and lifestyle issues.

The sample was composed of 281 healthy sedentary women aged 18-65 years (mean age 40.7 for the Commit to Quit group, 39.7 for the control group) who had regularly smoked 10 or more cigarettes a day for at least 3 years and who had exercised less than twice a week for at least 6 months. 

Exercise performance was measured prior to randomization and after 12 weeks of treatment. A graded maximal exercise test was performed on a stationary bike to measure functional capacity, expressed as estimated peak oxygen consumption per unit time (VO2). Cigarette smoking abstinence was measured by self-report questionnaire. Seven-day point prevalence abstinence (PPA) was obtained weekly during the 12-week program and 3 and 12 months after treatment. Continuous abstinence from quit day (week 4) to end of treatment (8 weeks later) and 3 and 12 months after treatment was also evaluated to examine sustained cessation, which relates more directly to health outcomes than 7-day PPA. Weight gain was defined as change in weight from baseline to the assessment period.

Back to Top

Key Findings

Effects of the Commit to Quit Program on Cigarette Smoking Abstinence

  • At the 3-month follow-up, 24.6% of Commit to Quit subjects had not smoked for the previous 7 days, as opposed to 13.6% of control subjects (p=.02). This difference did not hold at the 12-month follow-up.

  • Commit to Quit subjects were significantly more likely than control subjects to be continuously abstinent during the 8 weeks of treatment following quit day (19.4% versus 10.2%, p=.03), at the 3-month follow-up (16.4% versus 8.2%, p=.03, and at the 12-month follow-up (11.9% versus 5.4%, p=.05).

  • Commit to Quit subjects achieved significantly more days of continuous abstinence than control subjects at the end of treatment (mean+SD, 30.1+26.4 versus 17.3+22.4 days, p<.01), at 3-month follow-up (65.9+69.4 versus 36.0+56.6 days, p<.01), and at 12-month follow-up (127.1+164.1 versus 69.6+130.9 days, p<.01).

  • Compared with control subjects, Commit to Quit subjects were 35% less likely to have relapsed at the end of treatment (p<.01), 34% less likely to have relapsed 3 months after treatment (p=.01), and 36% less likely to have relapsed 12 months after treatment (p=.03).

Effects of the Commit to Quit Program on Weight Gain

  • Among quitters, Commit to Quit subjects had gained significantly less weight than control subjects at the end of treatment (mean+SD, 3.05+3.45 versus 5.40+6.94 kg; p=.03). This treatment effect did not hold for the two follow-up periods. 

Effects of the Commit to Quit Program on Exercise Performance

  • Among those attending the post-treatment exercise assessment, the estimated VO2 peak increased significantly with training in the Commit to Quit subjects (mean+SD, 25+6 mL/kg per minute at baseline, 28+6 mL/kg per minute at end of treatment; p<.01) but was unchanged in the control subjects (25+4 mL/kg per minute at baseline, 25+5 mL/kg per minute at end of treatment; ns).


Back to Top
Last Modified: 05/02/2012
  • View Notes

Use this area to take notes about how this program might work for you. Read More about RE-AIM.

Reach

Absolute number, proportion and representativeness of individuals who participate in the program.


(Max. 8 characters)

(Max. 8 characters)
(No max # of characters)
(No max # of characters)

Effectiveness

Impact on important outcomes, including potential negative effects, quality of life and economic factors.

(No max # of characters)
(No max # of characters)
(No max # of characters)

Adoption

Absolute number, proportion and representativeness of settings and intervention agents willing and able to initiate the program.

(No max # of characters)

Implementation

At the setting level- refers to the fidelity to the various elements of an intervention's protocol, including consistency of delivery as intended and the time and cost of the intervention. At the individual level- refers to clients' use of the intervention strategies.

(No max # of characters)

Maintenance

Please note that RE-AIM stands for Reach, Effectiveness, Adoption, Implementation and Maintenance. However, since “Maintenance” occurs after a program has been implemented, a notes section for this is not included as a part of this tool.